SHARES in FTSE 100 drugmaker Shire soared 430p to 3500p after it emerged as a £35billion takeover target for Japan’s biggest pharma company. Takeda Pharmaceutical is considering an approach to Shire as it looks to strengthen its core therapeutic areas of oncology and neuroscience.
-»
Japanese firm Takeda Pharmaceutical eyes up Shire as it considers an approach
![Japanese firm Takeda Pharmaceutical eyes up Shire as it considers an approach]()
Reviewed by Unknown
on
29 March
Rating:
No comments:
Post a Comment